This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business reverse stock split

Wellgistics Health completes reverse stock split

Analysis based on 9 articles · First reported May 20, 2026 · Last updated May 26, 2026

Sentiment
-20
Attention
2
Articles
9
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The reverse stock split by Wellgistics is intended to increase its share price to meet Nasdaq-100 listing requirements, potentially preventing delisting and stabilizing investor confidence. However, the underlying reasons for the low stock price, such as poor performance, may still concern investors, leading to continued volatility for Wellgistics's stock.

Health Information Technology Pharmaceuticals

Wellgistics, a Health IT company, completed a 1-for-50 reverse stock split of its common stock, effective May 26, 2026. This action, approved by stockholders on April 2, 2026, aims to increase the per share trading price to regain compliance with The Nasdaq-100 Capital Market's minimum bid price requirement. The split reduced outstanding shares from approximately 125.7 million to 2.5 million. No fractional shares were issued, with rounding up to the nearest whole share. The company's stock had been trading at $0.13, down 95% over the past year. Wellgistics is also exploring strategic opportunities, including potential acquisitions of WellCare Today and MiNK Therapeutics, and has formed a joint venture with KareRx Hub.

priv
Wellgistics completed a 1-for-50 reverse stock split to increase its share price and regain compliance with Nasdaq-100's minimum bid price requirement, which could prevent delisting but also reflects previous poor stock performance.
Importance 100.0 Sentiment -30.0
index
Nasdaq-100 is the exchange where Wellgistics's stock is listed, and its minimum bid price requirement is the reason for the reverse stock split.
Importance 70.0 Sentiment 0.0
oth
WellCare Today is a healthcare technology and remote monitoring company that Wellgistics is considering acquiring, indicating potential future expansion for Wellgistics.
Importance 10.0 Sentiment 0.0
oth
KareRx Hub formed a joint venture with Wellgistics to combine their pharmaceutical technology platforms, aiming to enhance prescription processing.
Importance 10.0 Sentiment 0.0
stock
MiNK Therapeutics is a neuroscience-focused research organization that Wellgistics is considering acquiring through an all-stock transaction, suggesting further diversification for Wellgistics.
Importance 10.0 Sentiment 0.0
priv
Wellgistics ended its Settlement Agreement with Silverback Capital, which involved the issuance of common stock, indicating a resolution or change in previous financial arrangements.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.